Gastric acid secretion inhibiting composition
US7815940B2 · kind B2 · utility
4Cited by
17References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 17, 2002 |
| Grant date | Oct 19, 2010 |
| Priority date | — |
| Expiry date | Jun 24, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An oral pharmaceutical dosage form comprises pharmacologically effective amounts of an acid susceptible proton pump inhibitor or a salt thereof, an H2 receptor antagonist or a salt thereof and a pharmaceutically acceptable carrier. The dosage form is capable of raising gastric pH to above 4 within two hours after administration and to keep it at that level for at least 4 hours. Also disclosed is a method of manufacture of the dosage form, its use in treating dyspepsia and infection by Helicobacter pylori, and a method of treating disorders associated with gastric acid secretion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.